Type 1 Diabetes
Type 1 Diabetes is a chronic condition where the pancreas produces little or no insulin, leading to high blood sugar levels. It often develops in children and young adults, requiring lifelong management with insulin therapy.
Type 1 Diabetes: NNC0194-0499 and Semaglutide Study
We are exploring how a new treatment and its combination with semaglutide can help control blood sugar in people with type 1 diabetes. This study aims to improve management options for those living with this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Novo Nordisk A/S
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.